Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

The method effectively detects banned substances in urine for sports antidoping.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

A woman with hair loss regrew hair using minoxidil and spironolactone.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.